Search

for
Search:

Research

5 / 1000+ results

research US clinics marketing unproven and unlicensed adipose-derived autologous stem cell interventions

20 citations , May 2015 in “Regenerative Medicine”

This commentary explores the marketing of unproven and unlicensed adipose-derived stem cell treatments in US clinics, highlighting concerns about patient safety and regulatory challenges.

research Alopecia: unapproved treatments or indications

22 citations , March 2000 in “Clinics in Dermatology”

This study developed a method using HPLC with UV-DAD and ESI-MS detection to identify prohibited substances like minoxidil and hormones in cosmetic products advertised online for hair loss and skin conditions.

Direct-To-Consumer Pharmaceutical Advertising: The Debate Is Not Over

research DTC pharmaceutical advertising: the debate’s not over

37 citations , May 2003 in “Journal of Consumer Marketing”

This review discusses consumers' positive attitudes towards direct-to-consumer pharmaceutical advertising, highlighting its impact on patient engagement despite physicians' mixed opinions on its influence on the doctor-patient relationship.

research Off Label Medication and Use of Unapproved Drugs

September 2016

This review discusses the off-label use of drugs like Minoxidil, Aripripazole, and others, providing insights for physicians and pharmacists but reports no new clinical findings.

Androgenetic Alopecia: Treatments and Efficacy

research ANDROGENETIC ALOPECIA

30 citations , January 2000 in “Dermatologic Clinics”

This article reviews the genetic and psychological aspects of androgenetic alopecia in men and women, reporting no new clinical findings while emphasizing the broad impact of this hair loss condition.

View more "fda-unapproved medical devices" in research →

Community Join

4 / 1000+ results

community Dermatologist denied prescribing oral dutasteride because it’s not FDA approved BUT did prescribe ORAL minoxidil 😂

in Finasteride/Dutasteride 31 upvotes 2 years ago

A 22-year-old male has been using oral finasteride for a year with no improvement in hair loss and was denied dutasteride by a dermatologist due to FDA approval issues but was prescribed oral minoxidil instead. The user is seeking advice on whether to switch to dutasteride, continue finasteride, or add minoxidil.

community How many years can we expect PP405 to be on the market

11 upvotes 1 year ago

PP405 is expected to be on the market between 2027 and 2030, with phase 3 trials starting in 2026. There is skepticism about its fast-tracking due to its cosmetic nature, and it may appear on the gray market sooner.

community 15 months total on Dut/Min/RU and microneedling 1mm every other week

1772 upvotes 2 years ago

The user reported significant hair improvement over 15 months using dutasteride, minoxidil (oral and topical), RU58841, ketoconazole, and microneedling. They are considering a hair transplant in 4-6 months.

community RU58841 is a scam until proven otherwise

15 upvotes 1 month ago

RU58841 is considered ineffective as a standalone treatment for hair loss, with users often combining it with finasteride and minoxidil for potential benefits. Many users report mixed results and concerns about side effects, leading to skepticism about its efficacy.

View more "fda-unapproved medical devices" in community →

Learn

— no results

Try a deeper search in learn →

Experts

— no results

Try a deeper search in experts →

Clinics

— no results

Try a deeper search in clinics →